Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)
COVID-SMELL
2 other identifiers
interventional
40
1 country
1
Brief Summary
The purpose of this study is to evaluate efficiency of two months of olfactive training on olfactory and taste loss secondary to covid-19. We will compare 2 groups : olfactive training group versus no olfactive training group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2022
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
September 24, 2025
CompletedOctober 2, 2025
September 1, 2025
1.3 years
September 22, 2025
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Taste and Smell Survey (TSS).
Patients will have this auto evaluation scale at the inclusion (D0) and 2 month after inclusion (D60).
Baseline and 2 months
Secondary Outcomes (2)
Sniffin' stick test :
2 month
Olfaction and taste evolution evaluated with a daily visual scale
Every day from inclusion to 2 months
Study Arms (2)
olfactory training arm
EXPERIMENTALwith a daily olfactory training during 2 month
no olfactory training
NO INTERVENTIONInterventions
Olfactory rehabilitation consists of smelling a series of spices every day for 2 months: vanilla, coffee, dill, thyme, cinnamon, cloves, lavender, coriander, light vinegar, mint, and cumin. This rehabilitation is based on the protocols proposed by SFORL (French ORL society) and Oleszkiewicz et al.8 Allergies to certain spices will be noted at the start of the study: * in known allergy: change by another spice which belongs to the same chemical category. * in case of allergies to several scents: patient is not included in the study. * in case of allergy appearing during participation: clinical evaluation by ENT, change by another spice which belongs to the same chemical category. * in case of allergies to several scents occuring during participation: patient is excluded from the study.
Eligibility Criteria
You may qualify if:
- SARS-CoV-2 infection suspect or confirmed
- supported by CHU Guadeloupe
- with brutal olfactory or taste loss
- affiliated or beneficiary of a social security scheme
- informed consent signed
You may not qualify if:
- recent rhinosinusitis, less than 6 months
- lingual pathology
- communication disorder
- Patients subject to a justice safeguard
- Allergy to several spices that are part of the rehabilitation set
- Pregnant or breastfeeding women
- Absence of signed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de La Guadeloupe
Pointe-à-Pitre, 97159, Guadeloupe
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suzy Duflo, MD PhD
CHU de la Guadeloupe
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2025
First Posted
September 24, 2025
Study Start
November 18, 2020
Primary Completion
March 9, 2022
Study Completion
March 9, 2022
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share